BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Callaghan C, Fanning LJ, Houston A, Barry OP. Loss of p38δ mitogen-activated protein kinase expression promotes oesophageal squamous cell carcinoma proliferation, migration and anchorage-independent growth. Int J Oncol 2013;43:405-15. [PMID: 23722928 DOI: 10.3892/ijo.2013.1968] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Zhou Q, Pan H, Wang L, Qian C. Association Study of MAP3K1 SNPs and Risk Factors with Susceptibility to Esophageal Squamous Cell Carcinoma in a Chinese Population: A Case-Control Study. Pharmgenomics Pers Med 2020;13:189-97. [PMID: 32753933 DOI: 10.2147/PGPM.S256230] [Reference Citation Analysis]
2 Bhushan A, Singh A, Kapur S, Borthakar BB, Sharma J, Rai AK, Kataki AC, Saxena S. Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets. OMICS 2017;21:616-31. [PMID: 29049013 DOI: 10.1089/omi.2017.0116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zheng S, Yang C, Liu T, Liu Q, Dai F, Sheyhidin I, Lu X. Clinicopathological significance of p38β, p38γ, and p38δ and its biological roles in esophageal squamous cell carcinoma. Tumour Biol 2016;37:7255-66. [PMID: 26666822 DOI: 10.1007/s13277-015-4610-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
4 Cuenda A, Sanz-Ezquerro JJ. p38γ and p38δ: From Spectators to Key Physiological Players. Trends Biochem Sci 2017;42:431-42. [PMID: 28473179 DOI: 10.1016/j.tibs.2017.02.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
5 O' Callaghan C, Fanning LJ, Barry OP. Hypermethylation of MAPK13 Promoter in Oesophageal Squamous Cell Carcinoma Is Associated with Loss of p38δ MAPK Expression. Cancers (Basel) 2015;7:2124-33. [PMID: 26512696 DOI: 10.3390/cancers7040881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Bliss-Moreau M, Coarfa C, Gunaratne PH, Guitart J, Krett NL, Rosen ST. Identification of p38β as a therapeutic target for the treatment of Sézary syndrome. J Invest Dermatol 2015;135:599-608. [PMID: 25148579 DOI: 10.1038/jid.2014.367] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
7 Bányai L, Trexler M, Kerekes K, Csuka O, Patthy L. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes. Elife 2021;10:e59629. [PMID: 33427197 DOI: 10.7554/eLife.59629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Anton DB, Ducati RG, Timmers LFSM, Laufer S, Goettert MI. A Special View of What Was Almost Forgotten: p38δ MAPK. Cancers (Basel) 2021;13:2077. [PMID: 33923030 DOI: 10.3390/cancers13092077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 O'Callaghan C, Fanning LJ, Barry OP. p38δ MAPK: Emerging Roles of a Neglected Isoform. Int J Cell Biol 2014;2014:272689. [PMID: 25313309 DOI: 10.1155/2014/272689] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
10 Wada M, Canals D, Adada M, Coant N, Salama MF, Helke KL, Arthur JS, Shroyer KR, Kitatani K, Obeid LM, Hannun YA. P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment. Oncogene 2017;36:6649-57. [PMID: 28783172 DOI: 10.1038/onc.2017.274] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
11 Rodríguez-Carballo E, Gámez B, Ventura F. p38 MAPK Signaling in Osteoblast Differentiation. Front Cell Dev Biol 2016;4:40. [PMID: 27200351 DOI: 10.3389/fcell.2016.00040] [Cited by in Crossref: 98] [Cited by in F6Publishing: 106] [Article Influence: 16.3] [Reference Citation Analysis]
12 García-Hernández L, García-Ortega MB, Ruiz-Alcalá G, Carrillo E, Marchal JA, García MÁ. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer. Int J Mol Sci 2021;23:370. [PMID: 35008796 DOI: 10.3390/ijms23010370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
13 O'Callaghan C, Fanning LJ, Barry OP. p38δ MAPK phenotype: an indicator of chemotherapeutic response in oesophageal squamous cell carcinoma. Anticancer Drugs 2015;26:46-55. [PMID: 25099621 DOI: 10.1097/CAD.0000000000000156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]